North America Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests

All the vital news, analysis, and commentary curated by our industry experts.

$5995

Buy Report

Published: July 09, 2025 Report Code: GDME20426CRDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “North America Metabolic Disorders Market Outlook to 2033” is a comprehensive databook report, covering key market data on the North America Metabolic Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Diabetes Assays and Cholesterol Tests

The North America Metabolic Disorders Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2024 company share data for Metabolic Disorders Market.
• Global corporate-level profiles of key companies operating within the North America Metabolic Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Metabolic Disorders is segmented as follows –

• Diabetes Assays

• Cholesterol Tests

Reasons to Buy

The North America Metabolic Disorders Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Abbott Laboratories
Alfa Wassermann Inc
ALPCO Diagnostics
Beckman Coulter Inc
Bio-Rad Laboratories Inc
Danaher Corp
DiaSorin SpA
EKF-diagnostic GmbH

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Metabolic Disorders Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Metabolic Disorders Market, North America 10

3.1 Metabolic Disorders Market, North America, Revenue ($m), 2018-2033 10

3.2 Metabolic Disorders Market, North America, Revenue ($m), 2018-2033 11

3.3 Metabolic Disorders Market, North America, Volume (Units), 2018-2033 13

3.4 Metabolic Disorders Market, North America, Volume (Units), 2018-2033 14

3.5 Metabolic Disorders Market, North America, Company Share by Revenue ($m), 2024 16

4 Metabolic Disorders Market, Canada 18

4.1 Metabolic Disorders Market, Canada, Revenue ($m), 2018-2033 18

4.1.1 Cholesterol Tests Market, Canada, Revenue ($m), by Segment, 2018-2033 20

4.1.2 Diabetes Assays Market, Canada, Revenue ($m), by Segment, 2018-2033 22

4.2 Metabolic Disorders Market, Canada, Volume (Units), 2018-2033 24

4.2.1 Cholesterol Tests Market, Canada, Volume (Units), by Segment, 2018-2033 26

4.2.2 Diabetes Assays Market, Canada, Volume (Units), by Segment, 2018-2033 29

4.3 Metabolic Disorders Market, Canada, Average Price ($), 2018-2033 31

4.4 Metabolic Disorders Market, Canada, Company Share by Revenue ($m), 2024 32

5 Metabolic Disorders Market, United States 34

5.1 Metabolic Disorders Market, United States, Revenue ($m), 2018-2033 34

5.1.1 Cholesterol Tests Market, United States, Revenue ($m), by Segment, 2018-2033 36

5.1.2 Diabetes Assays Market, United States, Revenue ($m), by Segment, 2018-2033 38

5.2 Metabolic Disorders Market, United States, Volume (Units), 2018-2033 40

5.2.1 Cholesterol Tests Market, United States, Volume (Units), by Segment, 2018-2033 42

5.2.2 Diabetes Assays Market, United States, Volume (Units), by Segment, 2018-2033 45

5.3 Metabolic Disorders Market, United States, Average Price ($), 2018-2033 48

5.4 Metabolic Disorders Market, United States, Company Share by Revenue ($m), 2024 49

6 Metabolic Disorders Market, Mexico 51

6.1 Metabolic Disorders Market, Mexico, Revenue ($m), 2018-2033 51

6.1.1 Cholesterol Tests Market, Mexico, Revenue ($m), by Segment, 2018-2033 53

6.1.2 Diabetes Assays Market, Mexico, Revenue ($m), by Segment, 2018-2033 55

6.2 Metabolic Disorders Market, Mexico, Volume (Units), 2018-2033 57

6.2.1 Cholesterol Tests Market, Mexico, Volume (Units), by Segment, 2018-2033 59

6.2.2 Diabetes Assays Market, Mexico, Volume (Units), by Segment, 2018-2033 62

6.3 Metabolic Disorders Market, Mexico, Average Price ($), 2018-2033 64

6.4 Metabolic Disorders Market, Mexico, Company Share by Revenue ($m), 2024 65

7 Overview of Key Companies in North America Metabolic Disorders Market 67

7.1 Abbott Laboratories 67

7.1.1 Company Overview 67

7.2 Siemens Healthineers AG 67

7.2.1 Company Overview 67

7.3 Beckman Coulter Inc 67

7.3.1 Company Overview 67

7.4 Ortho Clinical Diagnostics Holdings Plc 68

7.4.1 Company Overview 68

7.5 Roche Diagnostics International Ltd 68

7.5.1 Company Overview 68

7.6 Bio-Rad Laboratories Inc 68

7.6.1 Company Overview 68

8 Metabolic Disorders Market Pipeline Products 69

9 Recent Developments 73

9.1 Product News 73

9.1.1 May 21, 2025: MedImpact Unveils MedEmpower Fuel AI Plate Scanner 73

9.1.2 Mar 21, 2025: Baylor Genetics Presents New Data on Genetic and Functional Testing to Diagnose Mitochondrial Disorders at 2025 ACMG Annual Clinical Genetics Meeting 73

9.1.3 Jan 06, 2025: Introducing isaac by PreEvnt – Non-Invasive Blood Glucose Alert Device at the CES Digital Health Exhibit 74

9.2 Strategy And Business Planning 74

9.2.1 Jul 17, 2024: New Opportunity to Improve Diagnosis Care for People with Cardiovascular-Kidney-Metabolic Syndrome 74

10 Appendix 76

10.1 Research Methodology 77

10.1.1 Coverage 77

10.1.2 Secondary Research 77

10.1.3 Primary Research 77

10.1.4 Market Modeling and Forecasting 78

10.1.5 Company Share Analysis 79

10.1.6 Benchmarking 80

10.2 GlobalData Consulting 81

10.3 Contact Us 81

10.4 Disclaimer 81

Table

Table 1: Metabolic Disorders Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 10

Table 2: Metabolic Disorders Market, North America, Revenue ($m), USD Constant, 2018-2033 12

Table 3: Metabolic Disorders Market, North America, Volume (Units), 2018-2033 13

Table 4: Metabolic Disorders Market, North America, Volume (Units), 2018-2033 15

Table 5: Metabolic Disorders Market, North America, Company Share by Revenue ($m), 2024 17

Table 6: Metabolic Disorders Market, Canada, Revenue ($m), USD Constant, 2018-2033 19

Table 7: Cholesterol Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033 21

Table 8: Diabetes Assays Market, Canada, Revenue ($m), USD Constant, 2018-2033 23

Table 9: Metabolic Disorders Market, Canada, Volume (Units), 2018-2033 25

Table 10: Cholesterol Tests Market, Canada, Volume (Units), 2018-2033 27

Table 11: Diabetes Assays Market, Canada, Volume (Units), 2018-2033 30

Table 12: Metabolic Disorders Market, Canada, Average Price ($), 2018-2033 31

Table 13: Metabolic Disorders Market, Canada, Company Share by Revenue ($m), 2024 33

Table 14: Metabolic Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033 35

Table 15: Cholesterol Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 37

Table 16: Diabetes Assays Market, United States, Revenue ($m), USD Constant, 2018-2033 39

Table 17: Metabolic Disorders Market, United States, Volume (Units), 2018-2033 41

Table 18: Cholesterol Tests Market, United States, Volume (Units), 2018-2033 43

Table 19: Diabetes Assays Market, United States, Volume (Units), 2018-2033 46

Table 20: Metabolic Disorders Market, United States, Average Price ($), 2018-2033 48

Table 21: Metabolic Disorders Market, United States, Company Share by Revenue ($m), 2024 50

Table 22: Metabolic Disorders Market, Mexico, Revenue ($m), USD Constant, 2018-2033 52

Table 23: Cholesterol Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033 54

Table 24: Diabetes Assays Market, Mexico, Revenue ($m), USD Constant, 2018-2033 56

Table 25: Metabolic Disorders Market, Mexico, Volume (Units), 2018-2033 58

Table 26: Cholesterol Tests Market, Mexico, Volume (Units), 2018-2033 60

Table 27: Diabetes Assays Market, Mexico, Volume (Units), 2018-2033 63

Table 28: Metabolic Disorders Market, Mexico, Average Price ($), 2018-2033 64

Table 29: Metabolic Disorders Market, Mexico, Company Share by Revenue ($m), 2024 66

Table 36: Metabolic Disorders Market Pipeline Products 69

Table 13: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 78

Figures

Figure 1: Metabolic Disorders Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2018-2033 10

Figure 2: Metabolic Disorders Market, North America, Revenue ($m), USD Constant, 2018-2033 11

Figure 3: Metabolic Disorders Market, North America, Volume (Units), 2018-2033 13

Figure 4: Metabolic Disorders Market, North America, Volume (Units), 2018-2033 14

Figure 5: Metabolic Disorders Market, North America, Company Share (%), 2024 16

Figure 6: Metabolic Disorders Market, Canada, Revenue ($m), USD Constant, 2018-2033 18

Figure 7: Cholesterol Tests Market, Canada, Revenue ($m), USD Constant, 2018-2033 20

Figure 8: Diabetes Assays Market, Canada, Revenue ($m), USD Constant, 2018-2033 22

Figure 9: Metabolic Disorders Market, Canada, Volume (Units), 2018-2033 24

Figure 10: Cholesterol Tests Market, Canada, Volume (Units), 2018-2033 26

Figure 11: Diabetes Assays Market, Canada, Volume (Units), 2018-2033 29

Figure 12: Metabolic Disorders Market, Canada, Company Share (%), 2024 32

Figure 13: Metabolic Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033 34

Figure 14: Cholesterol Tests Market, United States, Revenue ($m), USD Constant, 2018-2033 36

Figure 15: Diabetes Assays Market, United States, Revenue ($m), USD Constant, 2018-2033 38

Figure 16: Metabolic Disorders Market, United States, Volume (Units), 2018-2033 40

Figure 17: Cholesterol Tests Market, United States, Volume (Units), 2018-2033 42

Figure 18: Diabetes Assays Market, United States, Volume (Units), 2018-2033 45

Figure 19: Metabolic Disorders Market, United States, Company Share (%), 2024 49

Figure 20: Metabolic Disorders Market, Mexico, Revenue ($m), USD Constant, 2018-2033 51

Figure 21: Cholesterol Tests Market, Mexico, Revenue ($m), USD Constant, 2018-2033 53

Figure 22: Diabetes Assays Market, Mexico, Revenue ($m), USD Constant, 2018-2033 55

Figure 23: Metabolic Disorders Market, Mexico, Volume (Units), 2018-2033 57

Figure 24: Cholesterol Tests Market, Mexico, Volume (Units), 2018-2033 59

Figure 25: Diabetes Assays Market, Mexico, Volume (Units), 2018-2033 62

Figure 26: Metabolic Disorders Market, Mexico, Company Share (%), 2024 65

North America Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests standard reports

Currency USD

Single User

$5,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports

Medical Devices

New

Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…

Medical Devices

New

AI-designed Materials: Market Trends and Innovations

Medical Devices

New

Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests in real time.

Access a live North America Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

North America Metabolic Disorders Market Outlook to 2033: Diabetes Assays and Cholesterol Tests

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports